Search By Initial

Cas Index 2

• 256448-15-4 | 4-Aza-1-azoniabicyclo[2.2.2]octane, 1,1'-(1,12-dodecanediyl)bis-, dibromide (9CI) (Catalog# : G20382)
• 2119669-71-3 | Asciminib HCl (Catalog# : 1711223)Asciminib, also known as ABL001, is a potent allosteric inhibitor of BCR-ABL.
• 2095719-92-7 | ASTX-029 (Catalog# : 20298)ASTX029 is a highly potent and selective dual-mechanism ERK inhibitor. ASTX029 inhibi
• 2036272-55-4 | ALC-0315 (Catalog# : 20264)ALC-0315 is a synthetic cationic lipid (or ionizable lipid). It is a colorless oily m
• 2055597-12-9 | ASN007 (Catalog# : 20103001)ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum
• 2105904-82-1 | AB-680 (Catalog# : 2091501)AB-680 is highly potent, reversible and selective CD73 inhibitor. AB680 to be a rever
• 2230820-11-6 | AZD-7648 (Catalog# : 2071531)AZD-7648 is a potent and selective DNA-PK inhibitor.
• 239272-16-1 | AWZ1066S (Catalog# : 2071530)AWZ1066S is a highly specific anti-Wolbachia drug candidate for a short-course treatm
• 2088113-98-6 | AZ31 (Catalog# : 2071508)AZ31 is a potent and highly selective ATM inhibitor.
• 2098497-32-4 | (4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate (Catalog# : 2062312)
• 2097416-76-5 | AZD0364 (Catalog# : 206101)AZD-0364 is a potent and selectiveERK2inhibitor extracted from patent WO2017080979A1,
• 23687-26-5 | 6-AMINOISOQUINOLINE (Catalog# : S-203043)
• 255713-47-4 | A-119637 (Catalog# : 204603)A-119637 is a novel, selective and potent alpha1D antagonist.
• 2296729-00-3 | AMG-510 (Catalog# : 112193)AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA
• 2252403-56-6 | AMG-510 racemate (Catalog# : 112194)AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA
• 246529-22-6 | Aramchol (Catalog# : 6111903)Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With
• 2064292-12-0 | A1874 (Catalog# : 193287)A1874 is a nutlin-based and BRD4-degrading PROTAC which induces BRD4 degradation in c
• 2196204-23-4 | AZ1495 (Catalog# : 193222)AZ1495 is a potent and selective IRAK4 inhibitor.
• 2101291-07-8 | AZD-0284 (Catalog# : 19365)AZD-0284 is a potent, selective, inverse agonist of the nuclear receptor RORγ for th
• 202463-68-1 | AM281 (Catalog# : 19315)AM281 is a synthetic cannabinoid CB1 receptor antagonist.
• 2097416-76-5 | AZD0364 (Catalog# : 192275)AZD0364 is an ERK1 and/or ERK2 kinase for the treatment of cancer. ERK1 and ERK2 kina
• 2248003-60-1 | AZD3229 (Catalog# : 191287)AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal st
• 2057509-72-3 | AZD4573 free base (Catalog# : 191212)AZD-4573 is a selective, short-acting inhibitor of the serine/threonine cyclin-depend
• 289893-26-1 | Arimoclomol maleate (Catalog# : 188281)Arimoclomol, also known as BRX-220, is potentially useful for the treatment of Nieman
• 22816-60-0 | A22 hydrochloride (Catalog# : 186211)A22 is an inhibitor of MreB, an actin-like bacterial protein, and has been shown to a
• 2095393-15-8 | ARQ-531 (Catalog# : 185176)ARQ-531 is a potent and orally active BTK inhibitor with potential antineoplastic act
• 2089288-03-7 | AZD1390 (Catalog# : 18541)AZD1390 is a potent and selective ATM inhibitor with the ability to cross the blood-b
• 252017-04-2 | AZD7545 (Catalog# : 179136)AZD7545 is an inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2) (IC50 value of 6.4
• 2091134-35-7 | AZD4205 (Catalog# : 20178710)AZD4205 is a highly potent JAK1-selective kinase inhibitor with excellent preclinical
• 2002381-31-7 | APS-2-79 (Catalog# : 16122775)APS-2-79 is a MAPK antagonist that modulating KSR-dependent MAPK signalling by antago